Enanta Pharmaceuticals
ENTA
#8621
Rank
NZ$0.46 B
Marketcap
NZ$15.82
Share price
-18.56%
Change (1 day)
-30.24%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: NZ$0.46 Billion

As of November 2026 Enanta Pharmaceuticals has a market cap of NZ$0.46 Billion. This makes Enanta Pharmaceuticals the world's 8621th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.46 B-45.14%
2025NZ$0.83 B271.8%
2024NZ$0.22 B-27.92%
2023NZ$0.31 B-79.44%
2022NZ$1.52 B-32.12%
2021NZ$2.24 B91.62%
2020NZ$1.17 B-35.53%
2019NZ$1.81 B-11.45%
2018NZ$2.05 B29.87%
2017NZ$1.58 B71.61%
2016NZ$0.92 B1.55%
2015NZ$0.90 B-24.94%
2014NZ$1.20 B102.54%
2013NZ$0.59 B

End of Day market cap according to different sources

On Nov 17th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

NZ$0.46 Billion
by Nasdaq info icon info icon
NZ$0.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.221 T 264,980.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$546.97 B 118,642.40%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$942.02 B 204,401.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$246.50 B 53,412.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$643.26 B 139,545.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$228.23 B 49,447.53%๐Ÿ‡บ๐Ÿ‡ธ USA